Highlights Sleeve gastrectomy in patients with class 1 obesity is associated with greater weight loss, diabetes prevention, and diabetes remission compared to intensive nonoperative obesity treatment. Perioperative complication rates are low, but an elevated incidence of substance use disorder and self-harm can be seen after surgery. Sleeve gastrectomy may be an appropriate treatment option in selected patients with metabolic comorbidity and class 1 obesity.
The current BMI-based indications for bariatric surgery with a BMI of 35 or greater with at least one obesity-related comorbidity were established long back in a consensus meeting in 1991. 1 Inspired by the metabolic benefits for patients with severe obesity, several clinical trials since then have reported the beneficial results of gastric bypass for type 2 diabetes or hypertension, including with class 1 obesity. 2 We have…
